Using SPECT/CT the authors were able to demonstrate greater and faster tumor cell uptake of the aptamer-HAuNS conjugate compared to antibody-HAuNS conjugates, suggesting a promising aptamer-based image guided drug delivery mechanism for EGFR positive head and neck cancers. This evidence concerns the gene EGFR and head and neck cancer.